Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
细菌非酮糖酸和聚糖的化学酶法合成
基本信息
- 批准号:10364735
- 负责人:
- 金额:$ 30.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-05 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcidsAcinetobacter baumanniiAnabolismAnimalsAntibioticsAntibodiesBacteriaBacterial InfectionsBacterial PolysaccharidesCarbohydratesCarbonChemicalsComplexConjugate VaccinesDevelopmentEnterobacter cloacaeEnzyme ActivationEnzymesEscherichia coliExcisionFamilyFundingFutureGenerationsGlycoconjugatesGlycosidesImmune systemIn SituKeto AcidsLibrariesLigaseLipopolysaccharidesMammalsMethodsMonitorMonosaccharidesOligosaccharidesPhosphotransferasesPolysaccharidesProcessProductionPropylaminesProteinsReactionReagentResearchRoleSialic AcidsSurfaceSystemUridine Diphosphate GalactoseUridine Diphosphate SugarsVertebral columnVertebratesVirulence Factorschemical synthesiscombatdesignglycosylationglycosyltransferasehost-microbe interactionsimprovedinhibitorpathogenic bacteriasugarsugar nucleotidetoolvaccine candidate
项目摘要
Project Summary
Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
Sialic acids are a family of wide-spread nonulosonic acids (alpha-keto acids with a nine-carbon backbone) in
vertebrates and in some pathogenic bacteria. Bacteria also produce nonulosonic acids that have not been
found in animals. These bacterium-specific nonulosonic acids have been used by bacteria as part of their
capsular polysaccharides (CPSs) and lipopolysaccharides (LPSs) which are bacterial virulence factors and
potential vaccine candidates. Structurally defined bacterial CPSs, LPSs, and the corresponding
oligosaccharide repeating units are important probes to study their roles in bacterial infection and microbe-host
interaction including their influence on host immune systems. These carbohydrates are attractive synthetic
targets but pose significant synthetic challenges. In addition to bacterial specific nonulosonic acids, they may
contain other monosaccharide building blocks that have not been found in mammals. The glycosidic linkages
found in bacterial polysaccharides are also much more diverse than those in mammalian glycans. We propose
to develop efficient chemoenzymatic methods to synthesize bacterial nonulosonic acids and their glycans as
part of CPS and LPS oligosaccharides of pathogenic bacteria. These represent biologically important and
synthetically challenging targets. In the current proposal duration, the focus will be on bacterial glycans
containing legionaminic acid and their derivatives. Three specific aims are: 1, Synthesize acceptors and
monosaccharide chemoenzymatic synthons for one-pot multienzyme (OPME) glycosylation systems; 2,
Identify and characterize candidate sugar-1-P kinases, UDP-sugar synthetases, and glycosyltransferases; and
3, Chemoenzymatic synthesis of bacterial polysaccharide repeating units containing legionaminic acid or
derivatives. The enzymes identified and the monosaccharides designed are important tools and reagents for
accessing synthetic challenging carbohydrates and glycoconjugates that are not limited to the targets
described in the proposal. The oligosaccharides produced are essential probes for better understanding the
important roles of bacterial polysaccharides. They are also candidates for synthesizing structurally defined
carbohydrate-protein conjugate vaccines to combat bacterial infections.
项目摘要
细菌壬糖酸和聚糖的化学酶法合成
唾液酸是一个广泛分布的壬酮糖酸(具有九个碳骨架的α-酮酸)家族,
脊椎动物和一些致病细菌。细菌还产生非酮糖酸,
在动物身上发现的。这些细菌特异性非酮糖酸已被细菌用作其代谢的一部分。
作为细菌毒力因子的荚膜多糖(CPS)和脂多糖(LPS),
潜在的疫苗候选人结构上确定的细菌CPS、LPS和相应的
寡糖重复单元是研究其在细菌感染和微生物-宿主关系中作用的重要探针
相互作用,包括它们对宿主免疫系统的影响。这些碳水化合物是有吸引力的合成
目标,但构成重大的合成挑战。除了细菌特异性的非酮糖酸外,它们还可以
还含有其他在哺乳动物中未发现的单糖结构单元。的糖苷键
在细菌多糖中发现的多糖也比在哺乳动物聚糖中发现的多糖多样得多。我们提出
开发有效的化学酶法合成细菌壬糖酸及其聚糖,
病原菌的部分CPS和LPS寡糖。这些代表了生物学上的重要性,
综合挑战性目标。在目前的提案期限内,重点将放在细菌聚糖上
含有军团胺酸及其衍生物。具体目标有三:1、合成受体,
用于一锅多酶(OPME)糖基化系统的单糖化学酶促反应; 2,
鉴定和表征候选糖-1-P激酶、UDP-糖合成酶和糖基转移酶;以及
3、化学酶法合成含有军团菌胺酸或
衍生物.所鉴定的酶和所设计的单糖是重要的工具和试剂,
获得合成的挑战性碳水化合物和糖缀合物,
提案中所述。所产生的寡糖是更好地了解
细菌多糖的重要作用。它们也是合成结构定义的
碳水化合物-蛋白质缀合物疫苗以对抗细菌感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xi Chen其他文献
Xi Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xi Chen', 18)}}的其他基金
High-throughput closed-loop direct aberration sensing and correction for multiphoton imaging in live animals
用于活体动物多光子成像的高通量闭环直接像差传感和校正
- 批准号:
10572572 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Crosstalk between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer
MYC 驱动的乳腺癌中 ER 应激反应与线粒体脂肪酸氧化之间的串扰
- 批准号:
10581179 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
突变 KRAS 驱动的癌症中的蛋白质稳态重编程
- 批准号:
10587281 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care
了解阿尔茨海默病及相关痴呆症和医疗保健中种族和民族差异的生命全程方法
- 批准号:
10650381 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care
了解阿尔茨海默病及相关痴呆症和医疗保健中的种族和民族差异的生命全程方法
- 批准号:
10448032 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
Chemoenzymatic construction of synthetic human milk oligosaccharide (HMO) glycome
合成人乳低聚糖 (HMO) 糖组的化学酶法构建
- 批准号:
10567752 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
Chemoenzymatic construction of synthetic human milk oligosaccharide (HMO) glycome
合成人乳低聚糖 (HMO) 糖组的化学酶法构建
- 批准号:
10710393 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
Elucidating perifoveal vascular development in infants
阐明婴儿中心凹周围血管发育
- 批准号:
10696178 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
Improving oral health awareness and dental referrals for adult patients receiving palliative care
提高接受姑息治疗的成年患者的口腔健康意识和牙科转诊
- 批准号:
10348739 - 财政年份:2021
- 资助金额:
$ 30.78万 - 项目类别:
Chemoenzymatic synthesis of bacterial nonulosonic acids and glycans
细菌非酮糖酸和聚糖的化学酶法合成
- 批准号:
10553186 - 财政年份:2021
- 资助金额:
$ 30.78万 - 项目类别:
相似海外基金
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 30.78万 - 项目类别:
Research Grant
Generative machine learning for narrow spectrum antibiotic discovery against Acinetobacter baumannii
生成机器学习用于发现针对鲍曼不动杆菌的窄谱抗生素
- 批准号:
477936 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Operating Grants
Conserved structural dynamics of outer-membrane channels in Acinetobacter baumannii as potential drug targets
鲍曼不动杆菌外膜通道的保守结构动力学作为潜在的药物靶点
- 批准号:
494854 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Operating Grants
Defining key players at the host-pathogen interface during Acinetobacter baumannii infection
定义鲍曼不动杆菌感染期间宿主-病原体界面的关键参与者
- 批准号:
488684 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Operating Grants
Study of clinically over-expressed and chimeric RND multidrug efflux pumps from Acinetobacter baumannii and Pseudomonas aeruginosa
鲍曼不动杆菌和铜绿假单胞菌临床过表达和嵌合 RND 多药外排泵的研究
- 批准号:
23K14346 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
仿生巨噬细胞膜包被的纳米海绵:一种治疗多重耐药铜绿假单胞菌和鲍曼不动杆菌医院相关肺炎的新疗法
- 批准号:
10674406 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Using strain history to improve prediction of the evolution of antimicrobial resistance in Acinetobacter baumannii
利用菌株历史改进对鲍曼不动杆菌抗菌药物耐药性演变的预测
- 批准号:
10677362 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Inhibitors of adaptive efflux mediated resistance in Acinetobacter baumannii
鲍曼不动杆菌适应性外排介导的耐药性抑制剂
- 批准号:
10625029 - 财政年份:2023
- 资助金额:
$ 30.78万 - 项目类别:
Identifying niche specific adaptations in Acinetobacter baumannii
鉴定鲍曼不动杆菌的生态位特异性适应
- 批准号:
10449699 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别:
Identifying niche specific adaptations in Acinetobacter baumannii
鉴定鲍曼不动杆菌的生态位特异性适应
- 批准号:
10596620 - 财政年份:2022
- 资助金额:
$ 30.78万 - 项目类别: